In early-stage research protocols, some participants reported mild, short-lived lethargy and a head rush sensation after TB-500 injection. These effects typically resolved within hours. However, these observations come from small, uncontrolled research cohorts—not large randomized trials. Serious adverse events have not been systematically documented [1].
The biggest unknown is long-term safety. TB-500 promotes cell migration and reduces inflammation, which is good for wound healing. But uncontrolled cell migration can theoretically increase cancer risk if used chronically. No human registry tracks TB-500 users over years, so we simply don't know whether it's safe for months or years of use [1].
Animal studies show TB-500 is well-tolerated at research doses, but animal data doesn't always predict human outcomes. Until large Phase 2 and Phase 3 human trials are complete and published, the FDA cannot confirm safety. Using TB-500 outside a clinical trial means you're accepting unknown risks [1].
Try This Today
Never use TB-500 without medical supervision. If you're enrolled in a clinical trial, your research team monitors you closely. If you buy it online, you have zero safety oversight and no way to report problems to the FDA.